Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.191
+0.001 (0.74%)
At close: Jan 17, 2025, 4:00 PM
0.192
+0.001 (0.37%)
After-hours: Jan 17, 2025, 7:58 PM EST
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$71,488
Profits / Employee
-$150,534
Market Cap
10.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
APDN News
- 10 days ago - Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - Accesswire
- 12 days ago - Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Accesswire
- 4 weeks ago - Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - Accesswire
- 4 weeks ago - Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - Accesswire
- 5 weeks ago - Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - Accesswire
- 2 months ago - Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - Accesswire
- 3 months ago - Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - Accesswire
- 4 months ago - Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire